| Literature DB >> 25128184 |
Zenghui Wang, Dongmei Wang, Sihao Zheng, Labin Wu, Linfang Huang1, Shilin Chen.
Abstract
BACKGROUND: The long term use of Rheum palmatum for the treatment of diseases associated with chronic hepatitis and renal failure can lead to liver and kidney damage. To reduce the toxicity of R. palmatum and alleviate any symptoms of decanta and celialgia, the raw material has been subjected to a specific process prior to its use for hundreds of years. Despite its extensive use in medicine, very little is currently known about the nature of the components present in this material in terms of their efficacy and overall toxicity, and the effect that processing has on the levels of these components in the processed material. The aim of this investigation was to explore potential differences in the chemical markers between batches of raw and processed R. palmatum and to develop a deeper understanding of the underlying mechanisms responsible for the enhanced efficacy and reduced toxicity of the processed material.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25128184 PMCID: PMC4147172 DOI: 10.1186/1472-6882-14-302
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Strategy proposed for rapidly exploring potential chemical markers for discrimination of raw and processed by UPLC–QTOF-MS coupled with multivariate statistical analysis.
Figure 2Extracted ion chromatograms (EIC) of 18 components for . The peaks labeling coincide with Table 1.
Tentative compounds in by UPLC-QTOF/MS in negative ion
| Peak no. | tR(min) | m/z experimental | m/z calculated | Tentative compounds | Molecular formula | Mass error (ppm) | Reference |
|---|---|---|---|---|---|---|---|
| S1 | 1.43 | 331.0667 | 331.0667 | Gallic acid-3-O-glucoside | C13H15O10 | 0 | [ |
| S2 | 3.57 | 439.0883 | 439.0883 | Aloe-emodin-glucoside derivate | C21H19O10 | −1.3 | [ |
| S3 | 3.96 | 289.0707 | 289.0712 | Catechin | C15H13O6 | −1.7 | [ |
| S4 | 4.88 | 729.1470 | 729.1456 | Catechin dimer derivate | C40H69O8 | 1.9 | [ |
| S5 | 6.86 | 441.0825 | 441.0822 | Epicatechin-3-O-gallate | C22H17O10 | 0.7 | [ |
| S6 | 7.33 | 477.1397 | 477.1397 | Cinnamyl-galloyl-glucoside derivative | C23H25O11 | 0 | [ |
| S7 | 7.50 | 257.0827 | 257.0814 | Emodin-O-glucoside | C15H13O4 | 5.1 | [ |
| S8 | 7.71 | 269.0450 | 269.0450 | Aloe-emodin | C15H10O5 | 0 | [ |
| S9 | 7.99 | 451.3296 | 451.3271 | Catechin-glucopyranoside | C21H24O11 | 5.5 | [ |
| S10 | 8.08 | 443.1345 | 443.1345 | Catechin-glucopyranoside derivative | C23H23O9 | −1.7 | [ |
| S11 | 8.62 | 461.1085 | 461.1084 | Cinnamyl-galloyl-glucoside derivative | C23H25O11 | 0.2 | [ |
| S12 | 8.95 | 677.4994 | 677.4993 | Catechin dimer derivate | C40H69O8 | 0.3 | [ |
| S13 | 9.28 | 245.0824 | 245.0814 | Torachrysone | C14H14O4 | 0 | [ |
| S14 | 9.71 | 253.0499 | 253.0501 | Chrysophanol | C15H9O4 | −0.8 | [ |
| S15 | 9.81 | 431.0988 | 431.0978 | Emodin-8-O-glucoside | C21H19O10 | 2.3 | [ |
| S16 | 10.20 | 281.0814 | 281.0811 | Chrysophanol dimethyl ether | C17H14O4 | −1.1 | [ |
| S17 | 10.73 | 426.9665 | 426.9691 | Rhein-1-O-(O-acetyl)-glucoside | C4H11O23 | −6.1 | [ |
| S18 | 11.34 | 269.0446 | 269.0450 | Emodin | C15H10O5 | −1.5 | [ |
Figure 3PCA generated by the Pareto of raw and processed R: Raw DH (sdh) C: Charred (dht) DH P: Prepared DH (hudh) W: Wine DH (jdh) V: Vinegar DH (cdh).
Figure 4OPLS-DA/S-plot (A) and selected ion intensity trend plots (B) of raw and processed Group1: Raw DH Group2: Processed DH.
Figure 5OPLS-DA(S-plot) of Raw and Processed Sample: A Raw DH vs. Wine DH; B Raw DH vs. Vinegar DH; C Raw DH vs. Prepared DH; D Raw DH vs. Charred DH.
Marker t -m/z ion pairs of raw and processed
| Raw DH/Processed DH | Raw DH/ vinegar DH | Raw DH/ wine DH | RawDH/ prepared DH | Raw DH/ charred DH | |||||
|---|---|---|---|---|---|---|---|---|---|
| tR- m/z | tR- m/z | tR- m/z | tR- m/z | tR- m/z | |||||
| Raw DH | 9.81-431.0988(a) | Raw DH | 9.81-431.0988(a) | Raw DH | 9.81-431.0988(a) | Raw DH | 9.81-431.0988(a) | Raw DH | 9.81-431.0988(a) |
| 7.99-451.3296 | 7.99-451.3296 | 7.99-451.3296 | 7.99-451.3296 | 7.99-451.3296 | |||||
| 3.57-431.0861 | 3.57-431.0861 | 3.57-431.0861 | 3.57-431.0861 | 3.57-431.0861 | |||||
| Processed DH | 1.43- 331.0667(d) | Vinegar DH | 1.43-331.0667(d) | Wine DH | 1.43-331.0667(d) | Prepared DH | 1.43-331.0667(d) | Charred DH | 1.43-331.0667(d) |
| 9.71- 253.0499 | 7.33-477.1396(g) | 7.33-477.1396(g) | 10.20-281.0814 | 10.20-281.0841 | |||||
| 10.20-281.0814 | 8.60-283.0291 | 8.60-283.0291 | 9.71- 253.0499(h) | 9.71-253.0499(h) | |||||
Palmatum samples in the S-plot.
aEmodin-8-O-glucoside, dGallic acid-3-O-glucoside,
gCinnamyl-galloyl-glucoside derivative, hChrysophanol.
Toxicity, property and characteristic components of raw and processed DH
| Toxic | Raw DH | Wine DH | Vinegar DH | Prepared DH | Charred DH | References |
|---|---|---|---|---|---|---|
| Nephrotoxicity | √ | ↓ | ↓ | ↓ | ↓ | [ |
| Hepatotoxicity | √ | ↓ | ↓ | ↓ | ↓ | [ |
| Gastrointestinal reactions | √ | ↓ | ↓ | ↓ | ↓ | [ |
| The property of bitter cold | √ | ↓ | ↓ | ↓ | ↓ | [ |
| Characteristic components | Aloe-emodin | Cinnamyl-galloyl | Cinnamyl-galloyl | Gallic acid | Gallic acid | [ |
| -glucoside | -glucoside | -glucoside | chrysophanol | chrysophanol | [ |
↓: Reduced toxic effects.
√: Toxic.